Hypericin-bearing magnetic iron oxide nanoparticles for selective drug delivery in photodynamic therapy
Unterweger H, Subatzus D, Tietze R, Janko C, Poettler M, Stiegelschmitt A, Schuster M, Maake C, Boccaccini AR, Alexiou C (2015)
Publication Status: Published
Publication Type: Journal article, Original article
Publication year: 2015
Journal
Book Volume: 10
Pages Range: 6985-6996
DOI: 10.2147/IJN.S92336
Abstract
Combining the concept of magnetic drug targeting and photodynamic therapy is a promising approach for the treatment of cancer. A high selectivity as well as significant fewer side effects can be achieved by this method, since the therapeutic treatment only takes place in the area where accumulation of the particles by an external electromagnet and radiation by a laser system overlap. In this article, a novel hypericin-bearing drug delivery system has been developed by synthesis of superparamagnetic iron oxide nanoparticles (SPIONs) with a hypericin-linked functionalized dextran coating. For that, sterically stabilized dextran-coated SPIONs were produced by coprecipitation and crosslinking with epichlorohydrin to enhance stability. Carboxymethylation of the dextran shell provided a functionalized platform for linking hypericin via glutaraldehyde. Particle sizes obtained by dynamic light scattering were in a range of 55-85 nm, whereas investigation of single magnetite or maghemite particle diameter was performed by transmission electron microscopy and X-ray diffraction and resulted in approximately 4.5-5.0 nm. Surface chemistry of those particles was evaluated by Fourier transform infrared spectroscopy and ζ potential measurements, indicating successful functionalization and dispersal stabilization due to a mixture of steric and electrostatic repulsion. Flow cytometry revealed no toxicity of pure nanoparticles as well as hypericin without exposure to light on Jurkat T-cells, whereas the combination of hypericin, alone or loaded on particles, with light-induced cell death in a concentration and exposure time-dependent manner due to the generation of reactive oxygen species. In conclusion, the combination of SPIONs’ targeting abilities with hypericin’s phototoxic properties represents a promising approach for merging magnetic drug targeting with photodynamic therapy for the treatment of cancer.
Authors with CRIS profile
Harald Unterweger
Department of Otorhinolaryngology – Head and Neck Surgery
Rainer Tietze
Department of Otorhinolaryngology – Head and Neck Surgery
Christina Janko
Lehrstuhl für Genetik
Alfons Stiegelschmitt
Lehrstuhl für Glas und Keramik
Matthias Schuster
Institute Materials for Electronics and Energy Technology (i-MEET)
Aldo Boccaccini
Lehrstuhl für Werkstoffwissenschaften (Biomaterialien)
Christoph Alexiou
Professur für Nanomedizin
Additional Organisation(s)
Involved external institutions
Switzerland (CH)How to cite
APA:
Unterweger, H., Subatzus, D., Tietze, R., Janko, C., Poettler, M., Stiegelschmitt, A.,... Alexiou, C. (2015). Hypericin-bearing magnetic iron oxide nanoparticles for selective drug delivery in photodynamic therapy. International Journal of Nanomedicine, 10, 6985-6996. https://dx.doi.org/10.2147/IJN.S92336
MLA:
Unterweger, Harald, et al. "Hypericin-bearing magnetic iron oxide nanoparticles for selective drug delivery in photodynamic therapy." International Journal of Nanomedicine 10 (2015): 6985-6996.
BibTeX: Download